Clinical Trials Logo

Maternal Exposure clinical trials

View clinical trials related to Maternal Exposure.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04721782 Active, not recruiting - Ultrasound Clinical Trials

Effects of Maternal Smoking on Fetal Liver Circulation

Start date: July 7, 2020
Phase:
Study type: Observational [Patient Registry]

According to the hypothesis of this study presented, the effects of smoking on the fetus can be determined by the liver circulation and hepatic metabolism. The basic assumption of this project is; Compensatory and pathological findings can be seen in the fetal liver circulation in babies of mothers who smoke and the findings can be valuable in predicting the direction of fetal development (growth retardation or normal development). In this study, the flow and shunt amounts in the fetal hepatic vessels in normal and smoking pregnant women will be calculated with the help of Doppler US.

NCT ID: NCT03851120 Active, not recruiting - Health Behavior Clinical Trials

Brain Probiotic and LC-PUFA Intervention for Optimum Early Life

BRAVE
Start date: October 31, 2019
Phase: Phase 2
Study type: Interventional

Probiotics is suggested to play several roles in promoting health, including alleviating disease symptoms, protection against atopic disease, and modulating the immune system by improving the beneficial gut microbiota colonization. The discovery of the gut microbiota-brain axis suggested that there is a reciprocal influence between the brain and the gut through a constant communication. This bi-directional axis enables signals to be transferred from brain to influence sensory, motor, and secretory modalities of the GI tract, also permits signal from the gut to influence brain function. The establishment of intestinal microbiota during early neurodevelopmental period suggests the colonization and maturation of gut microbiota may influence brain development. Several studies have shown there is an association between shifts in the gut microbiota composition in children with neurodevelopmental disorders. This study aims to investigate how maternal probiotic + LC-PUFA supported with government program supplements, healthy eating, and psychosocial stimulation could affect fetal brain development and later child brain functions and cognitive development. Intervention would be delivered to pregnant women for 9 months, starting at the end of second trimester of gestational period.